US Bancorp DE Acquires 1,158 Shares of Semler Scientific, Inc. (NASDAQ:SMLR)

US Bancorp DE increased its holdings in shares of Semler Scientific, Inc. (NASDAQ:SMLR) by 60.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,064 shares of the company’s stock after acquiring an additional 1,158 shares during the quarter. US Bancorp DE’s holdings in Semler Scientific were worth $72,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the business. Pinnacle Associates Ltd. raised its position in shares of Semler Scientific by 83.9% in the third quarter. Pinnacle Associates Ltd. now owns 29,346 shares of the company’s stock valued at $691,000 after purchasing an additional 13,392 shares during the period. Shariaportfolio Inc. acquired a new position in shares of Semler Scientific in the third quarter valued at approximately $3,618,000. Newbridge Financial Services Group Inc. bought a new position in shares of Semler Scientific during the second quarter worth approximately $34,000. AQR Capital Management LLC lifted its holdings in Semler Scientific by 150.1% during the 2nd quarter. AQR Capital Management LLC now owns 140,498 shares of the company’s stock worth $4,833,000 after purchasing an additional 84,314 shares during the last quarter. Finally, Citizens Financial Group Inc. RI bought a new stake in Semler Scientific in the 2nd quarter valued at $585,000. Institutional investors own 49.37% of the company’s stock.

Semler Scientific Price Performance

SMLR stock opened at $44.48 on Friday. The business’s fifty day moving average price is $29.23 and its two-hundred day moving average price is $29.76. The stock has a market capitalization of $323.37 million, a price-to-earnings ratio of 21.70 and a beta of 0.92. Semler Scientific, Inc. has a fifty-two week low of $20.88 and a fifty-two week high of $58.78.

Semler Scientific (NASDAQ:SMLR) last issued its quarterly earnings data on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The business had revenue of $13.51 million during the quarter.

Insider Activity at Semler Scientific

In other Semler Scientific news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $28.35, for a total transaction of $283,500.00. Following the sale, the chief executive officer now directly owns 60,220 shares in the company, valued at $1,707,237. This represents a 14.24 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 30.20% of the stock is currently owned by corporate insiders.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.